Lancet 2021; 398: 1965-1973.
Normal View Dyslexic View
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial.
1 January 2022
Randomized clinical trials Upper GI
Lancet 2021; 398: 1965-1973.
This multicentre study included 288 patients randomized to lifestyle intervention with additional intragastric balloon therapy. After 32 weeks, mean total bodyweight loss was greater in the balloon group: 15 versus 3.3 per cent (P,0.0001). Some 17 per cent of balloons were removed for intolerance.
Published on: 1 January 2022
Article ID: rct256


.png)





.jpg)
